CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...